Kainu, Annette
Vartiainen, Ville A.
Mazur, Witold
Hisinger-Mölkänen, Hanna http://orcid.org/0000-0003-2293-0279
Lavorini, Federico
Janson, Christer
Andersson, Martin
Clinical trials referenced in this document:
Documents that mention this clinical trial
Successful Use of Easyhaler® Dry Powder Inhaler in Patients with Chronic Obstructive Pulmonary Disease; Analysis of Peak Inspiratory Flow from Three Clinical Trials
https://doi.org/10.1007/s41030-023-00246-8
Documents that mention this clinical trial
Successful Use of Easyhaler® Dry Powder Inhaler in Patients with Chronic Obstructive Pulmonary Disease; Analysis of Peak Inspiratory Flow from Three Clinical Trials
https://doi.org/10.1007/s41030-023-00246-8
Funding for this research was provided by:
Orion Pharma
Article History
Received: 3 July 2023
Accepted: 17 November 2023
First Online: 3 January 2024
Declarations
:
: Annette Kainu has received consultation and lecture fees from ALK Nordic A/S, GSK Finland, and Orion Pharma. Witold Mazur had attended advisory boards and received lecture fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Orion Pharma, and Sanofi. Ville Vartianen has received consultation and lecture fees from Orion Pharma. Hanna Hisinger Molkanen is an employee of Orion Pharma. Christer Janson has received a research grant from AstraZeneca, received speaker honoraria from AstraZeneca, Boehringer Ingelheim, Chiesi, Glaxo Smith Kline, Novartis, Orion Pharma, and Sanofi-Genzyme, and has participated in the scientific advisory boards of AstraZeneca, Boehringer Ingelheim, Chiesi, Glaxo Smith Kline, Novartis, Orion Pharma, and Sanofi-Genzyme. Martin Anderrson and Federico Lavorini have nothing to declare.
: The study protocols were reviewed by regional ethical committees according to their region of conduct and were conducted according to the Declaration of Helsinki. Written informed consent was obtained from each subject prior to the study. The Ethics Committee of the Helsinki University Hospital District for the sites in Finland, and the Research Ethics Committee of the University of Tartu (UT REC) for the sites in Estonia.